1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with thromboxanes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahsan, F; Alam, F; Blood, AB; Giri, PC; Hanson, SFL; Moretta, DT; Power, GG; Terry, MH; Wilson, SM | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and thromboxanes
Article | Year |
---|---|
Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Inhalation; Aerosols; Animals; Animals, Newborn; Antihypertensive Agents; Arterial Pressure; Cardiac Output; Disease Models, Animal; Female; Heart Rate; Hypertension, Pulmonary; Infusions, Intravenous; Male; Protein Kinase Inhibitors; Pulmonary Artery; rho-Associated Kinases; Sheep, Domestic; Thromboxanes; Vascular Resistance; Vasodilator Agents | 2018 |